Viewing StudyNCT03522298



Ignite Creation Date: 2024-05-06 @ 11:28 AM
Last Modification Date: 2024-10-26 @ 12:45 PM
Study NCT ID: NCT03522298
Status: COMPLETED
Last Update Posted: 2024-03-15
First Post: 2018-03-20

Brief Title: Safety Pharmacokinetics and Efficacy of Paxalisib GDC-0084 in Newly-diagnosed Glioblastoma
Sponsor: Kazia Therapeutics Limited
Organization: Kazia Therapeutics Limited

Conditions & Keywords Data

Conditions:
Name
Glioblastoma Adult
Keywords:
Name View
unmethylated O6 methylguanine-methyltransferase MGMT promoter status View
newly diagnosed View